SLING THERAPEUTICS
Sling Therapeutics is a biopharmaceutical company focused on late-stage development for thyroid eye disease, aspiring to improve the lives of patients and their families.
SLING THERAPEUTICS
Industry:
Biopharma Biotechnology
Founded:
2020-01-01
Address:
Ann Arbor, Michigan, United States
Country:
United States
Website Url:
http://www.slingtx.com
Status:
Active
Email Addresses:
[email protected]
Total Funding:
35 M USD
Current Advisors List
Investors List
The Rise Fund
The Rise Fund investment in Series A - Sling Therapeutics
Official Site Inspections
http://www.slingtx.com Semrush global rank: 5.98 M Semrush visits lastest month: 1.37 K
- Host name: 23.185.0.253
- IP address: 23.185.0.253
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Sling Therapeutics"
About Us - Sling Therapeutics
Sling Therapeutics is a biopharmaceutical company focused on late-stage development for thyroid eye disease, aspiring to improve the lives of patients and their families. Our team, consisting of highly experienced executives, drug …See details»
Sling Therapeutics - Crunchbase Company Profile & Funding
Jun 13, 2022 Organization. Sling Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Sling Therapeutics is a …See details»
Sling Therapeutics - LinkedIn
Sling Therapeutics | 1,264 followers on LinkedIn. Focused on late-stage development of an oral small molecule for the treatment of thyroid eye disease (TED). | We are a clinical-stage ...See details»
Sling Therapeutics Launches with $35M Series A Financing to …
Jun 13, 2022 Sling Therapeutics has built a management team that has extensive drug development and operations experience: Ryan Zeidan, Ph.D., President and Chief Executive …See details»
About SLING THERAPEUTICS | DxMultiomics
Slingtx.com. Mark. Sling Therapeutics, Inc., is a biopharmaceutical company focused on late-stage development of an oral small molecule for the treatment of thyroid eye disease (TED). …See details»
Sling Therapeutics - Company Profile - Tracxn
Nov 5, 2024 Sling Therapeutics - Developer of therapeutics for the treatment of autoimmune and rare diseases. Raised a total funding of $35M over 1 round from 1 investor. Sling Therapeutics …See details»
Sling Therapeutics - VentureRadar
Website: https://slingtx.com/ Develops oral small molecules for thyroid eye disease treatment, focusing on late-stage development and Phase 2b clinical trials.See details»
Sling Therapeutics - Wiki - Golden
Sling Therapeutics is a biopharmaceutical company focused on late-stage development for thyroid eye disease.See details»
Sling Therapeutics Presents Data Demonstrating Linsitinib Prevents ...
Jun 17, 2023 – Treatment with linsitinib in a clinically relevant mouse model demonstrated a significant reduction in autoimmune response and classical Thyroid Eye Disease (TED) …See details»
Sling Therapeutics to Participate in Upcoming Investor ... - BioSpace
ANN ARBOR, Mich., Nov. 8, 2023 /PRNewswire/ -- Sling Therapeutics, Inc., a biopharmaceutical company focused on late-stage development of an oral small molecule for the treatment of …See details»
Sling Therapeutics - Owler
Sling Therapeutics’s Profile, Revenue and Employees. Sling Therapeutics is a Michigan-based biopharmaceutical company that researches and commercializes oral small molecules for the …See details»
Catherine Radovich - Sling Therapeutics
Catherine Radovich VP Clinical Operations Catherine Radovich is the Vice President of Clinical Operations at Sling Therapeutics, Inc. Ms. Radovich has over 25 years’ experience in clinical …See details»
Sling Therapeutics Email Format | slingtx.com Emails
[email protected]: 100.0%. Email Verification Tool Instantly check any Sling Therapeutics email. Get free lookups per month. Verify Top Sling Therapeutics Employees Ryan Zeidan …See details»
Sign In to Your Sling TV Account | Watch Live TV Online
Sign in to your Sling TV account and start watching your favorite live TV + movies, sports and more!See details»
Sling Therapeutics Initiates Enrollment in Phase 2b LIDS Clinical …
Jul 25, 2022 – First oral IGF-1R inhibitor to enter late-stage clinical trials for thyroid eye disease – – Global study being conducted in the U.S., Canada, UK, and Europe – Ann Arbor, MI, July …See details»
Sling TV - Wikipedia
Sling TV is an American streaming television service operated by Sling TV LLC, a wholly owned subsidiary of Dish Network.Unveiled on January 5, 2015, at the Consumer Electronics Show, …See details»
Sling Therapeutics Announces Publication Demonstrating …
Sep 25, 2023 – Linsitinib inhibited the formation of CD4+ T-cells in bone marrow, which are upregulated and clinically relevant in Thyroid Eye Disease (TED) – – Ongoing global Phase 2b …See details»
Sling TV: Stream Live TV Channels, Sports, & News Online
Ditch cable & stream live TV for the best price with Sling. Watch live news, sports, movies, and entertainment + top channels like ESPN, TNT, TBS and more.See details»
Sling Therapeutics Launches with $35M Series A Financing to …
Jun 13, 2022 – Company receives FDA IND clearance for linsitinib and prepares to initiate Phase 2b clinical trial – Ann Arbor, MI, June 13, 2022 — Sling Therapeutics, Inc., a …See details»